:


Akashi el al: Severe infectious mononudeosis-like syndrome and primary human herpesvirus 6 infection in an adult. N Engl J Med 329:168, 1993

Balfour HH et al: A randomi/ed, placebo-controlled trial of oral renal allografts. N Engl J Med 320:1381, 1989

Bowden RA et al: Cytomegalovirus (CMV)-specific intravenous immunoglobulin for the prevention of primary CMV infection and disease after marrow transplant. J Infect Dis 164:483, 1991

Buhles WC et al: Oanciclovir treatment of life- or sight-threaten ing Cytomegalovirus infection: Experience in 314 immunocompromised patients. Rev Infect Dis 10:8495, 1988

Cesarman E et al: Kaposi's sarcoma-associated heipesvirus-like DNA sequences in AlDS-related body-cavity based lymphomas. N Engl J Med 332:1186, 1995

Chang Yet al: Identification of herpesvirus-likeDNAsequences in AIDS-associated Kaposi's sarcoma. Science 266:1865, 1994

Drew WL et al: Oral ganciclovir as maintenance treatment for Cytomegalovirus retinitis in patients with AIDS. N EnglJ Med 333:615, 1995

Hirsch MS: The treatment of Cytomegalovirus in AIDS: More than meets the eye. N Engl J Med 326:262, 1992

Ho M: Cytomegalovirus: Biology and infection, 2d ed. New York, Plenum Press, 1991

Jabs DA: Controversies in the treatment of Cytomegalovirus re(i- nitis: Foscarnet versus ganciclovir. Infect Agents Dis 4:131, 1995

Leach CT et al: Human herpesvirus6 infection of the female genital tract. J Infect Dis 169:1281, 1994

Manez R et al: Time to detection of Cytomegalovirus (CMV) DNA in blood leukocytes is a predictor for the development ofCMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation. J Infect Dis 173:1072, 1996

McCutchan JA: Cytomegalovirus infections of the nervous system in patients with AIDS. Clin Infect Dis 20:747,1995

Merigan TC et al: A controlled trial of ganciclovir to prevent cytome-galovirus disease after heart transplantation. N Engl J Med 326:1182, 1992

Monini P et al: Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N Engl J Med 334:116H, 1996

Onorato IM et al: Epidemiology of cytomegaloviral infections: Recommendations for prevention and control. Rev Infect Dis 7:479, 1985

Pass RF et al: Young children as a probable source of maternal and congenital cytomegalovirus infection. N Engl J Med 316:1366. 1987

Renne R et al: Lylic growth of Kaposi's sarcoma-associated herpes-virus (human herpesvirus 8) in culture. Nature Med 2:342, 1996

Smyth RL et al: Cytomegalovirus infection in heart-lung transplant recipients: Risk factors, clinical associations, and response to treatment. J Tnfect Dis 164:1045, 1991

Snydman DR et al: Use of cytomegalovirus immune globulin to J Med 317:1049, 1987

Studies of Ocular Complications of Aids Research Group, Aids Clinical Trials Group: Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 326:213, 1992

Studies of Ocular Complications of Aids Research Group, Aids Clinical Trials Group: Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The cytomegalovirus retreatment trial. Arch Ophthalmol 114:23, 1996

Wyatt LS et al: Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J Virol 66:3206, 1992

:

  • (, , 5- )
  • (, )